Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr.
TipRanks on MSN
Vor Biopharma Appoints New Chief Medical Officer
On November 2, 2025, Vor Biopharma Inc. amended the employment agreement with its Chief Development Officer, Dr. Qing Zuraw, to include additional severance benefits in case of termination without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback